- This event has passed.
IUSTI World + European Congress
June 27, 2018 - June 30, 2018
Don’t miss out our Satellite Symposium
Visit us at Booth #24
This year combines the World and Europe IUSTI congress into one and it is looking to be a very exciting and relevant event. The congress will be hosted in Trinity College Dublin, running under the theme of “The Appliance of Science” – emphasising the great practical advances that science has brought to our day-to-day clinical practice with patients, and to public health.
The programme will tackle newly emerging issues in the STI field, including:
- the rise of Syphilis and other STIs
- confronting Gonococcal Resistance
- addressing Sexual Health and Quality Sex in STI practice
- how STI practice can be improved through Programme Science
Mark your calendars for the SpeeDx Satellite Symposium and be sure to visit us at Booth #24 to talk about your Molecular Diagnostic needs.
Diagnostics Defining Therapy – how resistance guided therapy is changing STI management
Thursday June 28th, 2:30-3:45PM, Emmet Theatre
Learn about the latest in Gonorrhoea surveillance, M. genitalium macrolide resistance testing in Scotland and Barcelona and be part of an interesting panel discussion.
Symposium Chair: Jeff Klausner
A/Prof David Whiley – The University of Queensland Centre for Clinical Research, Brisbane Australia
Dr Kate Templeton – Royal Infirmary Edinburgh, UK
Dr Mateu Espasa Soley – Vall d’Hebron Institut de Recerca, Barcelona, Spain
A/Prof David Whiley, Dr Kate Templeton, Dr Elisa Mokany
Key Presentations at IUSTI Dublin
Mycoplasma genitalium and fluoroquinolone resistance
Jorgen Skov Jensen
Date: Thursday June 28th
Atrium: Dining Hall @ 12:30 – 1:30PM
John White – Is Dual Therapy for Gonorrhea the Solution to the Threat of Antimicrobial Resistance?
Lisa Manhart – Resistance profiles and treatment outcomes among Mycoplasma genitalium (MG) infected men who have sex with men (MSM) with non-gonococcal urethritis (NGU)
Helen Fifer – The correlation between azithromycin minimum inhibitory concentration and clinical outcome for Gonorrhoea in the GTOG trial: does dual therapy treatment remain appropriate?
Date: Friday June 29th
Edmund Burke Hall @ 11:15 – 12:30PM
Abstract Presentation Title
Gyrase a genotyping of Neisseria Gonorrhoeae for the rapid prediction of ciprofloxacin susceptibility: implementation, patient outcomes, and cost analysis
Date: Friday June 29th
Hall: Beckett Room 1 @ 3:00 – 4:15PM